Association between psychological measures and brain natriuretic peptide in heart failure patients

References

• Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.
   PubMed Web of Science ®Google Scholar
• Konstam V, Moser DK, De Jong MJ. Depression and anxiety in heart failure. J Card Fail. 2005; 11:455–63.
   PubMed Web of Science ®Google Scholar
• Lee SC, Stevens TL, Sandberg SM, Heublein DM, Nelson SM, Jougasaki M, . The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail. 2002;8:149–54.
   PubMed Web of Science ®Google Scholar
• Mehra MR, Maisel A. B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use. Crit Pathw Cardiol. 2005;4:10–20.
   PubMedGoogle Scholar
• Tsuchida K, Tanabe K. Plasma brain natriuretic peptide concentrations and the risk of cardiovascular events and death in general practice. J Cardiol. 2008;52:212–23.
   PubMed Web of Science ®Google Scholar
• Wiedemann K, Jahn H, Kellner M. Effects of natriuretic peptides upon hypothalamo-pituitary-adrenocortical system activity and anxiety behaviour. Exp Clin Endocrinol Diabetes. 2000;108:5–13.
   PubMed Web of Science ®Google Scholar
• Parissis JT, Nikolaou M, Farmakis D, Bistola V, Paraskevaidis IA, Adamopoulos S, . Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart. 2008;94:585–9.
   PubMed Web of Science ®Google Scholar
• Politi P, Minoretti P, Piaggi N, Brondino N, Emanuele E. Elevated plasma N-terminal ProBNP levels in unmedicated patients with major depressive disorder. Neurosci Lett. 2007;417:322–5.
   PubMed Web of Science ®Google Scholar
• Bunevicius R, Varoneckas G, Prange AJ Jr., Hinderliter AL, Gintauskiene V, Girdler SS. Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender. Clin Cardiol. 2006;29:170–4.
   Google Scholar
• Gottlieb SS, Kop WJ, Ellis SJ, Binkley P, Howlett J, O’Connor C, . Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF- ACTION]). Am J Cardiol. 2009;103:1285–9.
   PubMed Web of Science ®Google Scholar
• Lesman-Leegte I, van Veldhuisen DJ, Hillege HL, Moser D, Sanderman R, Jaarsma T, . Depressive symptoms and outcomes in patients with heart failure: data from the COACH study. Eur J Heart Fail. 2009;11:1202–7.
   PubMed Web of Science ®Google Scholar
• Pelle AJ, van den Broek KC, Szabo B, Kupper N. The relationship between Type D personality and chronic heart failure is not confounded by disease severity as assessed by BNP. Int J Cardiol. 2009;5:82–3.
   Google Scholar
• Tsuchihashi-Makaya M, Kato N, Chishaki A, Takeshita A, Tsutsui H. Anxiety and poor social support are independently associated with adverse outcomes in patients with mild heart failure. Circ J. 2009;73:280–7.
   PubMed Web of Science ®Google Scholar
• Van den Broek KC, deFilippi CR, Christenson RH, Seliger SL, Gottdiener JS, Kop WJ, . Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality. American Journal of Cardiology. 2011;1:723–9.
   Google Scholar
• Laederach-Hofmann K, Roher-Gubeli R, Messerli N, Meyer K. Comprehensive rehabilitation in chronic heart failure–better psycho-emotional status related to quality of life, brain natriuretic peptide concentrations, and clinical severity of disease. Clin Invest Med. 2007;30:E54–E62.
   Google Scholar
• Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69–77.
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Snaith RP, Zigmond AS. The hospital anxiety and depression scale. Br Med J (Clin Res Ed). 1986;292:344.
   PubMed Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA. Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol. 1984; 40:1365–7.
   PubMed Web of Science ®Google Scholar
• Aben I, Verhey F, Lousberg R, Lodder J, Honig A. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics. 2002;43:386–93.
   PubMed Web of Science ®Google Scholar
• Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67:89–97.
   PubMed Web of Science ®Google Scholar
• Habra ME, Linden W, Anderson JC, Weinberg J. Type D personality is related to cardiovascular and neuroendocrine reactivity to acute stress. J Psychosom Res. 2003;55:235–45.
   PubMed Web of Science ®Google Scholar
• Ho JE, Levy D. B-type natriuretic peptide testing in the general population: are we ready for prime time? J Am Coll Cardiol. 2010;55:2148–9.
   PubMed Web of Science ®Google Scholar
• Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, . High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem. 2004;50:2052–8.
   PubMed Web of Science ®Google Scholar
• Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–37.
   PubMed Web of Science ®Google Scholar
• Kupper N, Pedersen SS, Hofer S, Saner H, Oldridge N, Denollet J, Cross-cultural analysis of Type D (distressed) personality in 6222 patients with ischemic heart disease: A study from the International HeartQoL Project. Int J Cardiol. 2011 Nov 10. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Scherer M, Stanske B, Wetzel D, Koschack J, Kochen MM, Herrmann-Lingen C, . Psychosocial co-symptoms in primary care patients with heart failure. Herz. 2006;31:347–54.
   PubMed Web of Science ®Google Scholar
• Pedersen SS, Denollet J, de Jonge P, Simsek C, Serruys PW, van Domburg RT, . Brief depression screening with the PHQ-2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting. J Gen Intern Med. 2009;24:1037–42.
   PubMed Web of Science ®Google Scholar